BIT
EVFM

BlackRock Institutional Trust’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

BlackRock Institutional Trust’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6K Hold
58
– – ﹤0.01% 3811
2016
Q3 		$6K Hold
58
– – ﹤0.01% 3853
2016
Q2 		$5K Hold
58
– – ﹤0.01% 3866
2016
Q1 		$3K Hold
58
– – ﹤0.01% 3918
2015
Q4 		$7K Hold
58
– – ﹤0.01% 3922
2015
Q3 		$42K Buy
+58
New +$62.3K ﹤0.01% 3829

Other funds holding EVFM

UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WAS
WESPAC Advisors SoCal Pasadena, California $560M AUM 37.11% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock Institutional Trust's EVFM Position: Q4 2016 in Review

BlackRock Institutional Trust held its Evofem Biosciences, Inc. Common Stock (EVFM) position steady in Q4 2016 at 58 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #3811.

BlackRock Institutional Trust first reported a position in EVFM in Q3 2015 and has held it in 6 quarters since. The position peaked at $42K in Q3 2015. 14 funds tracked by Wall St. Rank hold EVFM as of Q4 2016.

  • BlackRock Institutional Trust held 58 shares of Evofem Biosciences, Inc. Common Stock worth $6K as of Q4 2016.
  • BlackRock Institutional Trust left its Evofem Biosciences, Inc. Common Stock share count unchanged in Q4 2016.
  • Evofem Biosciences, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3811 holding.
  • BlackRock Institutional Trust first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Institutional Trust's Evofem Biosciences, Inc. Common Stock position peaked at $42K in Q3 2015.
  • 14 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.